As indicated by the results, the transcriptional levels of EGR1, EGR2, and EGR3 were significantly reduced in patients with BRCA (p < 0.05), whereas the expression level of EGR4 was very low in both breast cancer and normal breast tissues (Figure 1A). The gene discussed is EGR3; the disease is breast carcinoma.